UNSPSC 51281708: Sultamicillin

This classification denotes an anti-bacterial agent and ampicillin with the molecular formula C25H30N4O9S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65DT0ML581, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (((3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-yl)carbonyl)oxy)methyl ester, s,s-dioxide, (2s-(2alpha(2r*,5s*),5alpha,6beta(s*)))- but generally known as sultamicillin, which bears US NIH Compound Identifier 53512.

UNSPSC 51281708 Sultamicillin is a Commodity code nominally designating a specific antibiotic product, but recent state and local activity tagged to this code shows little alignment with sultamicillin procurement itself. Instead, the code appears in opportunities across a broader pharmaceutical and medical supply landscape, including naloxone kits, safe drug deactivation systems, first-aid and rescue supplies for fire departments, and multi-source generic pharmaceuticals and over-the-counter products. State and local governments issuing under or near this code include county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances spanning multiple states and jurisdictions. The work being solicited ranges from one-time or recurring purchases of specific pharmaceutical items to broader framework agreements with manufacturers and wholesalers supplying generic drugs and medical consumables to state facilities and local agencies.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a due date of July 26, 2023 (noting a date inconsistency in the source). The City of Tampa issued ITB 26P00145 on March 25, 2026, for medical and first aid supplies to the Tampa Fire Department, with an estimated contract value of $700,000 and a response deadline of March 13, 2026; this solicitation is sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for a Direct-to-Manufacturer Prescriptions program, seeking information on direct pharmacy benefit contracting outside traditional pharmacy benefit managers and wholesalers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities including Oregon, with proposals due March 26, 2026. Activity clusters in Florida, Texas, Minnesota, and the Pacific Northwest, with cooperative purchasing extending across multiple state jurisdictions.